FAM72D expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.145200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.478200E-01
Normal-vs-Stage2
8.152800E-01
Normal-vs-Stage3
4.490600E-01
Normal-vs-Stage4
8.567000E-01
Stage1-vs-Stage2
6.694800E-01
Stage1-vs-Stage3
3.372800E-01
Stage1-vs-Stage4
8.667400E-01
Stage2-vs-Stage3
2.344400E-01
Stage2-vs-Stage4
6.138200E-01
Stage3-vs-Stage4
3.921200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.813400E-01
Normal-vs-AfricanAmerican
9.552000E-01
Normal-vs-Asian
7.080200E-01
Caucasian-vs-AfricanAmerican
7.709200E-01
Caucasian-vs-Asian
1.636190E-01
AfricanAmerican-vs-Asian
6.795600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.667600E-01
Normal-vs-Female
9.652600E-01
Male-vs-Female
6.463600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.416600E-01
Normal-vs-Age(41-60Yrs)
8.226000E-01
Normal-vs-Age(61-80Yrs)
9.565000E-01
Normal-vs-Age(81-100Yrs)
7.457200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.832830E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.810350E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.258100E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.873800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.539800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.363200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.699000E-01
Normal-vs-Daily Drinker
8.850600E-01
Normal-vs-Weekly Drinker
8.025800E-01
Normal-vs-Occasional Drinker
9.687000E-01
Normal-vs-Social Drinker
7.014600E-01
Non Drinker-vs-Daily Drinker
4.941200E-01
Non Drinker-vs-Weekly Drinker
8.698400E-01
Non Drinker-vs-Occasional Drinker
7.740200E-01
Non Drinker-vs-Social Drinker
6.858800E-01
Daily Drinker-vs-Weekly Drinker
4.274200E-01
Daily Drinker-vs-Occasional Drinker
7.278000E-01
Daily Drinker-vs-Social Drinker
2.704600E-01
Weekly Drinker-vs-Occasional Drinker
6.666400E-01
Weekly Drinker-vs-Social Drinker
8.346800E-01
Occasional Drinker-vs-Social Drinker
4.902200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.166600E-01
Normal-vs-Grade 2
7.174200E-01
Normal-vs-Grade 3
7.920800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.476900E-03
Grade 1-vs-Grade 3
1.844840E-04
Grade 1-vs-Grade 4
6.166600E-01
Grade 2-vs-Grade 3
9.467600E-02
Grade 2-vs-Grade 4
7.174200E-01
Grade 3-vs-Grade 4
7.920800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.580200E-01
Normal-vs-NonDiabetic
7.914600E-01
Diabetic-vs-NonDiabetic
6.495100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.072200E-01
Normal-vs-NoPancreatitis
9.322400E-01
Pancreatitis-vs-NoPancreatitis
5.603800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.874400E-01
Normal-vs-N1
8.844000E-01
N0-vs-N1
8.703200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.488800E-01
Normal-vs-TP53-NonMutant
9.306600E-01
TP53-Mutant-vs-TP53-NonMutant
2.47649999995936E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
